No Picture
News

Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension

SAN DIEGO–(BUSINESS WIRE)—- $GOSS–Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension […]

No Picture
News

L?kahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform

RUTHERFORD, N.J. & LA JOLLA, Calif. & LOS ANGELES–(BUSINESS WIRE)–L?kahi Therapeutics™ Advances its Proprietary ai² PIPELINE Process from Internal Asset Engine to Revenue-Generating Platform. Click here to view original post Click Here to Publish/Feature Your […]

No Picture
Industry News

Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models

Genialis and Inventia Life Sciences agreed to work together to improve how new treatments for pancreatic cancer are tested and matched to the patients most likely to benefit. The companies will combine Genialis’ AI-powered patient […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

SAN DIEGO, Sept. 23, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its intention to offer, subject […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies

SAN DIEGO, Sept. 23, 2026 (GLOBE NEWSWIRE) — Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced expansion of optical genome mapping (OGM) based […]

News

Tempo Therapeutics Awarded $2.25 Million NIH SBIR Grant to Advance MAP™ Technology for Complex Wound Healing

Novel synthetic biomaterial is designed to support volumetric tissue regeneration while minimizing inflammatory foreign-body response SAN DIEGO, Sept. 23, 2026 /PRNewswire/ — Tempo Therapeutics, Inc. (“Tempo”), a clinical-stage regenerative medicine company pioneering synthetic… Click here […]

No Picture
News

Ionis announces positive interim data from partner Roche’s Phase 3 IMAgINATION study in IgA nephropathy (IgAN)

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and partner Roche today announced positive prespecified interim results from the ongoing Phase 3 IMAgINATION study evaluating investigational sefaxersen in adults with primary IgA nephropathy (IgAN). The study […]


ADVERTISEMENT — Advertise With Biotech Networks
News

100 Consecutive Sports Medicine Cases, Zero Documented Wound Complications With Brijjit® Tissue Bridges

100 consecutive orthopedic cases demonstrate the use of force-modulating tissue bridges across ACL, knee, shoulder, elbow and ankle procedures. SAN DIEGO, Sept. 22, 2026 /PRNewswire/ — BRIJ Medical today announced the publication of a new […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Circular Genomics and Altoida Announce Collaboration to Advance First-of-Kind Multimodal Precision Medicine for Alzheimer’s Disease

Companies aim to combine blood-based circRNA biomarkers of disease biology and pathology with objective digital measures of cognition and function, to accelerate Alzheimer’s drug development today and create a scalable frontline care tomorrow. SAN DIEGO […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update

SAN DIEGO, Sept. 21, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today reported financial […]

No Picture
News

Iambic Launches Enchant v3 – Molecular Superintelligence Designed to Advance End-to-End Drug Discovery & Development

SAN DIEGO–(BUSINESS WIRE)–Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today unveiled Enchant v3, the next generation of its multimodal transformer model built to advance end-to-end drug discovery […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

L?kahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent

RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–L?kahi Therapeutics™ renews its University of Alabama collaboration, advancing real-world asset evaluation and developing key future biopharma talent. Click here to view original post Click Here to Publish/Feature Your […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #65Roses–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that it will host […]

News

Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033

SAN DIEGO, Sept. 17, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme” or the “Company”), today announced the pricing of $1.3 billion aggregate principal amount of 1.50% convertible senior notes due 2033 (the “Convertible […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks